Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: A randomized clinical trial

JAMA

Volumn 312, Issue 2, 2014, Pages 155-161

  Koegelenberg, Coenraad F N ^a   Noor, Firdows ^a   Bateman, Eric D ^b   Van Zyl Smit, Richard N ^b   Bruning, Axel ^c   O'Brien, John A ^d   Smith, Clifford ^e   Abdool Gaffar, Mohamed S ^f   Emanuel, Shaunagh ^g   Esterhuizen, Tonya M ^a   Irusen, Elvis M ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Gatesville Melomed Hospital   (South Africa)

^d Christiaan Barnard Memorial Hospital   (South Africa)

^e Rochester Place Medical Centre   (South Africa)

^f Kingsway Medical Centre   (South Africa)

^g Synopsis Research Unit   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NICOTINE GUM; NICOTINE PATCH; PLACEBO; VARENICLINE;

ABNORMAL DREAMING; ADULT; AGED; ARTICLE; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEADACHE; HUMAN; INSOMNIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; SLEEP DISORDER; SMOKING CESSATION; SOUTH AFRICA; TARGET QUIT DATE; TOBACCO DEPENDENCE; TREATMENT DURATION;

ADULT; BENZAZEPINES; BREATH TESTS; CARBON MONOXIDE; CHOLINERGIC AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; QUINOXALINES; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 84903883633     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.7195     Document Type: Article

References (21)

1. Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368(4):341-350.
2. Jha P. Avoidable global cancer deaths and total deaths from smoking. Nat Rev Cancer. 2009;9(9):655-664.
3. Rigotti NA. Strategies to help a smoker who is struggling to quit. JAMA. 2012;308(15):1573-1580.
4. Gonzales D, Rennard SI, Nides M, et al; Varenicline Phase 3 Study Group. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):47-55.
5. Jorenby DE, Hays JT, Rigotti NA, et al; Varenicline Phase 3 Study Group. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):56-63.
6. Tonstad S, Tønnesen P, Hajek P, Williams KE, Billing CB, Reeves KR; Varenicline Phase 3 Study Group. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):64-71.
7. Benowitz NL. Nicotine addiction. N Engl J Med. 2010;362(24):2295-2303.
8. Prochaska JJ, Hilton JF. Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis. BMJ. 2012;344:e2856.
9. Hajek P, Smith KM, Dhanji AR, McRobbie H. Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? a randomised controlled trial. BMC Med. 2013;11:140.
10. Ebbert JO, Burke MV, Hays JT, Hurt RD. Combination treatment with varenicline and nicotine replacement therapy. Nicotine Tob Res. 2009;11(5):572-576.
11. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-1127.
12. Welsch SK, Smith SS, Wetter DW, Jorenby DE, Fiore MC, Baker TB. Development and validation of the Wisconsin Smoking Withdrawal Scale. Exp Clin Psychopharmacol. 1999;7(4):354-361.
13. Fiore MC, Jaén CR, Baker TB, et al. Treating Tobacco Use and Dependence: Quick Reference Guide for Clinicians. Rockville, MD: US Dept of Health and Human Services, Public Health Service; 2008.
14. Besada NA, Guerrero AC, Fernandez MI, Ulibarri MM, Jiménez-Ruiz CA. Clinical experience from a smokers clinic combining varenicline and nicotine gum. Eur Respir J. 2010;36(suppl 54):462s.
15. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013;5:CD009329.
16. Ebbert JO, Hatsukami DK, Croghan IT, et al. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial. JAMA. 2014;311(2):155-163.
17. Lindson-Hawley N, Aveyard P, Hughes JR. Reduction versus abrupt cessation in smokers who want to quit. Cochrane Database Syst Rev. 2012;11:CD008033.
18. Lindson-Hawley N, Aveyard P, Hughes JR. Gradual reduction vs abrupt cessation as a smoking cessation strategy in smokers who want to quit. JAMA. 2013;310(1):91-92.
19. Ossip DJ, Abrams SM, Mahoney MC, Sall D, Cummings KM. Adverse effects with use of nicotine replacement therapy among quitline clients. Nicotine Tob Res. 2009;11(4):408-417.
20. Harrison-Woolrych M, Paterson H, Tan M. Exposure to the smoking cessation medicine varenicline during pregnancy: a prospective nationwide cohort study. Pharmacoepidemiol Drug Saf. 2013;22(10):1086-1092.
21. Kaplan YC, Olgac Dündar N, Kasap B, Karadas B. Pregnancy outcome after varenicline exposure in the first trimester [published online February 3, 2014]. Case Rep Obstet Gynecol. doi:10.1155/2014/263981.